PT  - JOURNAL ARTICLE
AU  - Nwankwo, Ann
AU  - Iboi, Enahoro.
AU  - Okuonghae, Daniel
TI  - Impact of Vaccine Failure on the Transmission Dynamics of Measles in Nigeria
AID  - 10.1101/2021.02.25.21252459
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.25.21252459
4099  - http://medrxiv.org/content/early/2021/03/01/2021.02.25.21252459.short
4100  - http://medrxiv.org/content/early/2021/03/01/2021.02.25.21252459.full
AB  - Measles is a vaccine preventable disease. However, it is still a major public health challenge in Nigeria.We therefore formulate a mathematical model for the transmission of measles with a two dose vaccination strategy and weaning of vaccine derived immunity. Using weekly measles cases for Nigeria in 2020 from the Nigeria Center for Disease Control (NCDC), the model was validated. This modelling study via numerical simulations showed that there is a possibility of disease control with a ten fold increase in the vaccination rates. Also, it was shown that primary vaccine failure has more impact on disease dynamics than secondary vaccine failure. Thus control strategies should not just focus on increase the vaccination rates but also look at measures that will help in reducing primary vaccine failure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA